Cite
HARVARD Citation
Lüers, A. et al. (n.d.). 3119 P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI. European journal of cancer. pp. S643-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lüers, A. et al. (n.d.). 3119 P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI. European journal of cancer. pp. S643-. [Online].